Publications by Dr Oksana Pogoryelova - ePrints

Browsing publications by Dr Oksana Pogoryelova.

Newcastle Authors	Title	Year
Professor Grainne Gorman Dr Oksana Pogoryelova	Phase 2b program with sonlicromanol in patients with mitochondrial disease due to m.3243A>G mutation	2025
Dr Andreas Roos Dr Oksana Pogoryelova Dr Sally Spendiff Professor Hanns Lochmuller	Ion Mobility QTOF-MS Untargeted Lipidomics of Human Serum Reveals a Metabolic Fingerprint for GNE Myopathy	2024
Professor Hanns Lochmuller Dr Oksana Pogoryelova	A phase 3 randomized study evaluating sialic acid extended-release for GNE myopathy	2021
Professor Hanns Lochmuller Professor Rita Horvath Dr Oksana Pogoryelova	Results from a 3-year Non-interventional, Observational Disease Monitoring Program in Adults with GNE Myopathy	2021
Dr Oksana Pogoryelova Professor Hanns Lochmuller	Economic Costs of Myasthenia Gravis: A Systematic Review	2020
Dr Oksana Pogoryelova Dr Ian Wilson Professor Hanns Lochmuller	GNE genotype explains 20% of phenotypic variability in GNE myopathy	2019
Dr Oksana Pogoryelova Professor Hanns Lochmuller Dr Andreas Roos Dr Verena Willenbockel	237th ENMC International Workshop: GNE myopathy – current and future research Hoofddorp, The Netherlands, 14–16 September 2018	2019
Dr Hadil Alrohaif Dr Oksana Pogoryelova Professor Hanns Lochmuller	Gne myopathy in the bedouin population of Kuwait: Genetics, prevalence, and clinical description	2018
Dr Oksana Pogoryelova Jose Gonzalez Coraspe Dr Nikoletta Nikolenko Professor Hanns Lochmuller Dr Andreas Roos et al.	GNE myopathy: From clinics and genetics to pathology and research strategies	2018
Dr Oksana Pogoryelova Phillip Cammish Professor Hanns Lochmuller	Phenotypic stratification and genotype–phenotype correlation in a heterogeneous, international cohort of GNE myopathy patients: First report from the GNE myopathy Disease Monitoring Program, registry portion	2018
Dr Oksana Pogoryelova Professor Jordi Diaz Manera Professor Volker Straub Emerita Professor Katherine Bushby Professor Hanns Lochmuller et al.	Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database	2017
Dr Oksana Pogoryelova Professor Michela Guglieri Professor Chiara Marini Bettolo Professor Volker Straub Dr Teresinha Evangelista et al.	Reduced serum myostatin concentrations associated with genetic muscle disease progression	2017
Dr Oksana Pogoryelova Professor Hanns Lochmuller	Beevor's sign: a potential clinical marker for GNE myopathy	2016
Dr Oksana Pogoryelova Professor Hanns Lochmuller	Upper and lower extremity muscle strength decline over 1 year in a prospective, observational GNE-myopathy natural history study	2016
Dr Oksana Pogoryelova Professor Hanns Lochmuller	GNE myopathy in Roma patients homozygous for the p.I618T founder mutation	2015
Dr Oksana Pogoryelova Phillip Cammish Professor Hanns Lochmuller	GNE myopathy worldwide epidemiology based on the patient self-reported registry	2015
Dr Oksana Pogoryelova Professor Michela Guglieri Professor Volker Straub Emerita Professor Katherine Bushby Professor Hanns Lochmuller et al.	Muscle-Derived Proteins as Serum Biomarkers for Monitoring Disease Progression in Three Forms of Muscular Dystrophy	2015
Dr Ruairidh Martin Dr Oksana Pogoryelova Dr Mauro Santibanez Koref Dr John Bourke Professor Dawn Teare et al.	Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials	2014
Dr Amina Chaouch Dr Fiona Norwood Professor Rita Horvath Professor Patrick Chinnery Dr Tuomo Polvikoski et al.	Two recurrent mutations are associated with GNE myopathy in the North of Britain	2014